鼠李糖乳杆菌L34通过排泄抗炎分子减轻5/6肾切除小鼠模型的慢性肾脏病进展
在5/6肾切除小鼠模型中,每日喂食L34(1×10^6 CFU)14周后,与5/6Nx对照相比,L34治疗组肾脏纤维化面积更少(P<0.01),血清肌酐和蛋白尿更低,TMAO(P=0.02)、硫酸吲哚酚(P<0.01)、内毒素(P=0.03)和血清TNF-α(P=0.01)水平更低。体外实验显示L34条件培养基可减轻硫酸吲哚酚对Caco-2肠上皮细胞和HK2近端小管细胞的炎症及完整性损伤。结论认为L34通过减少肠源性尿毒症毒素和肠道渗漏减轻尿毒症诱导的全身炎症,从而发挥肾脏保护作用。
要点
- L34治疗组较5/6Nx对照组肾脏纤维化面积显著减少(P<0.01)。
- L34治疗组TMAO(P=0.02)、硫酸吲哚酚(P<0.01)、内毒素(P=0.03)和血清TNF-α(P=0.01)均低于5/6Nx对照组。
- 体外L34条件培养基可减轻硫酸吲哚酚诱导的Caco-2和HK2细胞炎症及屏障损伤。
核心结论
- L34通过减少肠源性尿毒症毒素和肠道渗漏减轻尿毒症诱导的全身炎症,在CKD中提供肾脏保护作用。
研究设计与样本
- 在5/6肾切除小鼠术后6周,每日喂食L34(1×10^6 CFU)或磷酸盐缓冲液(作为5/6Nx对照),持续14周。
- 体外评估L34条件培养基(含或不含硫酸吲哚酚)对Caco-2肠上皮细胞炎症和细胞完整性(跨上皮电阻;TEER)的影响,并在HK2近端小管细胞中评估对促炎细胞因子和胶原表达的影响。
主要发现
- 5/6Nx术后20周,L34治疗组较5/6Nx对照组肾脏纤维化面积更少(P<0.01),血清肌酐和蛋白尿更低。
- L34治疗组较5/6Nx对照组TMAO(P=0.02)、硫酸吲哚酚(P<0.01)、内毒素(P=0.03)和血清TNF-α(P=0.01)更低。
- 粪便微生物组分析显示5/6Nx对照组中拟杆菌门比例增加。
- 硫酸吲哚酚孵育后,Caco-2肠上皮细胞白细胞介素-8和核因子κB表达升高、TEER值降低,HK2细胞TNF-α、IL-6和胶原(III型和IV型)基因表达升高;L34条件培养基可减轻这些硫酸吲哚酚激活的参数。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although pathogenic gut microbiota causes gut leakage, increases translocation of uremic toxins into circulation and accelerates CKD progression, the local strain of Lactobacillus rhamnosus L34 might attenuate gut leakage. We explored the effects of L34 on kidney fibrosis and levels of gut-derived uremic toxins (GDUTs) in 5/6 nephrectomy (5/6Nx) mice. METHODS: At 6 weeks post-5/6Nx in mice, either L34 (1 × 106 CFU) or phosphate buffer solution (as 5/6Nx control) was fed daily for 14 weeks. In vitro, the effects of L34-conditioned media with or without indoxyl sulfate (a representative GDUT) on inflammation and cell integrity (transepithelial electrical resistance; TEER) were assessed in Caco-2 (enterocytes). In parallel, the effects on proinflammatory cytokines and collagen expression were assessed in HK2 proximal tubular cells. RESULTS: At 20 weeks post-5/6Nx, L34-treated mice showed significantly fewer renal injuries, as evaluated by (i) kidney fibrosis area (P < 0.01) with lower serum creatinine and proteinuria, (ii) GDUT including trimethylamine-N-oxide (TMAO) (P = 0.02) and indoxyl sulfate (P < 0.01) and (iii) endotoxin (P = 0.03) and serum TNF-α (P = 0.01) than 5/6Nx controls. Fecal microbiome analysis revealed an increased proportion of Bacteroidetes in 5/6Nx controls. After incubation with indoxyl sulfate, Caco-2 enterocytes had higher interleukin-8 and nuclear factor κB expression and lower TEER values, and HK2 cells demonstrated higher gene expression of TNF-α, IL-6 and collagen (types III and IV). These indoxyl sulfate-activated parameters were attenuated with L34-conditioned media, indicating the protective role of L34 in enterocyte integrity and renal fibrogenesis. CONCLUSION: L34 attenuated uremia-induced systemic inflammation by reducing GDUTs and gut leakage that provided renoprotective effects in CKD.
引用
- Tungsanga S, Katavetin P, Panpetch W, et al. Lactobacillus rhamnosus L34 attenuates chronic kidney disease progression in a 5/6 nephrectomy mouse model through the excretion of anti-inflammatory molecules. Nephrol Dial Transplant. 2022. PMID: 35138387. doi:10.1093/ndt/gfac032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。